ALFA Filings
Every announcement, straight from the exchange
Every GlaxoSmithKline Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GLAXOSMITHKLINE PHARMACEUTICALS disclosed its shareholding pattern as per regulatory requirements. No monetary or transactional event was announced.
GlaxoSmithKline Pharmaceuticals submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance, safety standards, and community initiatives.
GlaxoSmithKline Pharmaceuticals filed its Annual Secretarial Compliance Report for FY2026 showing full regulatory adherence. No fines or observations were reported by the practicing company secretary.
GlaxoSmithKline Pharmaceuticals Ltd has authorized specific personnel, including the Managing Director and CFO, to determine the materiality of events for disclosure under SEBI Regulations. This administrative update ensures compliance with Regulation 30(5) regarding timely communication to stock exchanges.